Pharmaceutical-Biotech Capital Investment Update: Mid-Atlantic Region Nudges California Out of Top Spot for 2006
Pharmaceutical-Biotech Capital Investment Update: Mid-Atlantic Region Nudges California Out of Top Spot for 2006
Attachment: Pharma-Biotech Industry Spending Analysis Chart
If each of the projects proceeds to construction this year, they will carry an average TIV of $65 million. This represents a 7.3% improvement over 2005 - Includes Pharma-Biotech Industry Spending Analysis Chart
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
